An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with alzheimer disease

Journal of Biological Chemistry

Volumn 288, Issue 32, 2013, Pages 23331-23347

  Cavallini, Annalisa ^a   Brewerton, Suzanne ^a   Bell, Amanda ^a   Sargent, Samantha ^a   Glover, Sarah ^a   Hardy, Clare ^a   Moore, Roger ^a   Calley, John ^a   Ramachandran, Devaki ^b   Poidinger, Michael ^b   Karran, Eric ^c   Davies, Peter ^d   Hutton, Michael ^a   Szekeres, Philip ^a   Bose, Suchira ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Eli Lilly Singapore Pte Ltd   (Singapore)

^c Alzheimer's Research UK   (United Kingdom)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEURODEGENERATIVE DISEASES;

ALZHEIMER DISEASE; CELL-BASED SCREENS; HYPERPHOSPHORYLATED; NEUROFIBRILLARY TANGLES; TAUOPATHIES;

ENZYMES;

GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 13; PHOSPHOTRANSFERASE; RAS PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL LYSATE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; MOUSE; NERVE CELL CULTURE; NEUROBLASTOMA CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TAUOPATHY;

EID: 84881448059     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.463984     Document Type: Article

References (41)

1. Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R. C., Stevens, M., de Graaff, E., Wauters, E., van Baren, J., Hillebrand, M., Joosse, M., Kwon, J. M., Nowotny, P., Che, L. K., Norton, J., Morris, J. C., Reed, L. A., Trojanowski, J., Basun, H., Lannfelt, L., Neystat, M., Fahn, S., Dark, F., Tannenberg, T., Dodd, P. R., Hayward, N., Kwok, J. B., Schofield, P. R., Andreadis, A., Snowden, J., Craufurd, D., Neary, D., Owen, F., Oostra, B. A., Hardy, J., Goate, A., van Swieten, J., Mann, D., Lynch, T., and Heutink, P. (1998) Association of missense and 5-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705
2. Lee, V. M., Brunden, K. R., Hutton, M., and Trojanowski, J. Q. (2011) Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. Cold Spring Harb. Perspect. Med. 1, a006437
3. Gómez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., and Hyman, B. T. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24
4. Trinczek, B., Biernat, J., Baumann, K., Mandelkow, E. M., and Mandelkow, E. (1995) Domains of tau protein differential phosphorylation, and dynamic instability of microtubules. Mol. Biol. Cell 6, 1887-1902
5. Sergeant, N., Bretteville, A., Hamdane, M., Caillet-Boudin, M. L., Grognet, P., Bombois, S., Blum, D., Delacourte, A., Pasquier, F., Vanmechelen, E., Schraen-Maschke, S., and Buée, L. (2008) Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteomics 5, 207-224
6. Hanger, D. P., Seereeram, A., and Noble, W. (2009) Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Rev. Neurother. 9, 1647-1666
7. Higuchi, M., Lee, V. M., and Trojanowski, J. Q. (2002) Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med. 2, 131-150
8. Eidenmüller, J., Fath, T., Hellwig, A., Reed, J., Sontag, E., and Brandt, R. (2000) Structural and functional implications of Tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins. Biochemistry 39, 13166-13175
9. Augustinack, J. C., Schneider, A., Mandelkow, E.-M., and Hyman, B. T. (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103, 26-35
10. Kimura, T., Ono, T., Takamatsu, J., Yamamoto, H., Ikegami, K., Kondo, A., Hasegawa, M., Ihara, Y., Miyamoto, E., and Miyakawa, T. (1996) Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments. Dementia 7, 177-181
11. Schneider, A., Biernat, J., von Bergen, M., Mandelkow, E., and Mandelkow, E. M. (1999) Phosphorylation that detaches tau protein from microtubules (Ser 262, Ser 214) also protects it against aggregation into Alzheimer's paired helical filaments. Biochemistry 38, 3549-3558
12. Cho, J. H., and Johnson, G. V. (2003) Glycogen synthase kinase 3phosphorylates at both primed and unprimed sites. Differential impact on microtubule binding. J. Biol. Chem. 278, 187-193
13. Wen, Y., Planel, E., Herman, M., Figueroa, H. Y., Wang, L., Liu, L., Lau, L.-F., Yu, W. H., and Duff, K. E. (2008) Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J. Neurosci. 28, 2624-2632
14. Andorfer, C., Kress, Y., Espinoza, M., de Silva, R., Tucker, K. L., Barde, Y. A., Duff, K., and Davies, P. (2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 86, 582-590
15. Nuss, J. M., Harrison, S. D., Ring, D. B., Boyce, R. S., Johnson, K., Pfister, K. B., Ramurthy, S., Seely, L., Wagman, A. S., Desai, M., and Levine, B. H. (October, 24 2002) U. S. Patent 20,020,156,087
16. Dijkstra, E. W. (1959) A note on two problems in connexion with graphs. Numerische Mathematik 1, 269-271
17. Punta, M., Coggill, P. C., Eberhardt, R. Y., Mistry, J., Tate, J., Boursnell, C., Pang, N., Forslund, K., Ceric, G., Clements, J., Heger, A., Holm, L., Sonnhammer, E. L., Eddy, S. R., Bateman, A., and Finn, R. D. (2012) The Pfam protein families database. Nucleic Acids Res. 40, D290-D301
18. Maas, T., Eidenmüller, J., and Brandt, R. (2000) Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J. Biol. Chem. 275, 15733-15740
19. Hernández, F., Lucas, J. J., Cuadros, R., and Avila, J. (2003) GSK-3 dependent phosphoepitopes recognized by PHF-1 and AT-8 antibodies are present in different tau isoforms. Neurobiol. Aging 24, 1087-1094
20. Alonso, A. C., Grundke-Iqbal, I., and Iqbal, K. (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2, 783-787
21. Hurtado, D. E., Molina-Porcel, L., Carroll, J. C., Macdonald, C., Aboagye, A. K., Trojanowski, J. Q., and Lee, V. M. (2012) Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease. J. Neurosci. 32, 7392-7402
22. Hanger, D. P., Anderton, B. H., and Noble, W. (2009b) Tau phosphorylation; the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 15, 112-119
23. Goedert, M., Hasegawa, M., Jakes, R., Lawler, S., Cuenda, A., and Cohen, P. (1997) Phosphorylation of microtubule-associated protein tau by stressactivated protein kinases. FEBS Lett. 409, 57-62
24. Buée-Scherrer, V., and Goedert, M. (2002) Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases in intact cells. FEBS Lett. 515, 151-154
25. Harper, S. J., and Wilkie, N. (2003) MAPKs: new targets for neurodegeneration. Expert Opin. Ther. Targets 7, 187-200
26. Ferrer, I., Blanco, R., Carmona, M., and Puig, B. (2001) Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/ calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J. Neural. Transm. 108, 1397-1415
27. Atzori, C., Ghetti, B., Piva, R., Srinivasan, A. N., Zolo, P., Delisle, M. B., Mirra, S. S., and Migheli, A. (2001) Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J. Neuropathol. Exp. Neurol. 60, 1190-1197
28. Allen, B., Ingram, E., Takao, M., Smith, M. J., Jakes, R., Virdee, K., Yoshida, H., Holzer, M., Craxton, M., Emson, P. C., Atzori, C., Migheli, A., Crowther, R. A., Ghetti, B., Spillantini, M. G., and Goedert, M. (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340-9351
29. Johnson, G. V., and Bailey, C. D. (2003) The p38 MAP kinase signaling pathway in Alzheimer's disease. Exp. Neurol. 183, 263-268
30. Lee, Y.-J., Han S. B., Nam, S.-Y., Oh, K.-W., and Hong, J. T. (2010) Inflammation and Alzheimer's disease. Arch. Pharm. Res. 33, 1539-1556
31. Azorsa, D. O., Robeson, R. H., Frost, D., Meec hoovet, B., Brautigam, G. R., Dickey, C., Beaudry, C., Basu, G. D., Holz, D. R., Hernandez, J. A., Bisanz, K. M., Gwinn, L., Grover, A., Rogers, J., Reiman, E. M., Hutton, M., Stephan, D. A., Mousses, S., and Dunckley, T. (2010) High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's diseaserelated tau hyperphosphorylation. BMC Genomics 11, 25
32. Bullido, M. J., Martínez-García, A., Tenorio, R., Sastre, I., Muñoz, D. G., Frank, A., and Valdivieso, F. (2008) Double stranded RNA activated EIF2kinase (EIF2AK2; PKR) is associated with Alzheimer's disease. Neurobiol. Aging 29, 1160-1166
33. Chang, R. C., Wong, A. K., Ng, H. K., and Hugon, J. (2002) Phosphorylation of eukaryotic initiation factor-2(eIF2) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 13, 2429-2432
34. Morris, M., Maeda, S., Vossel, K., and Mucke, L. (2011) The many faces of tau. Neuron 70, 410-426
35. Pooler, A. M., Usardi, A., Evans, C. J., Philpott, K. L., Noble, W., and Hanger, D. P. (2012) Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiol. Aging 33, 431.e27-431.e38
36. Shahpasand, K., Uemura, I., Saito, T., Asano, T., Hata, K., Shibata, K., Toyoshima, Y., Hasegawa, M., and Hisanaga, S. (2012) Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease. J. Neurosci. 32, 2430-2441
37. Reynolds, C. H., Garwood, C. J., Wray, S., Price, C., Kellie, S., Perera, T., Zvelebil, M., Yang, A., Sheppard, P. W., Varndell, I. M., Hanger, D. P., and Anderton, B. H. (2008) Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J. Biol. Chem. 283, 18177-18186
38. Min, S. W., Cho, S. H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., Meyers, D., Cole, P. A., Ott, M., and Gan, L. (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67, 953-966
39. Higuchi, M., Iwata, N., Matsuba, Y., Takano, J., Suemoto, T., Maeda, J., Ji, B., Ono, M., Staufenbiel, M., Suhara, T., and Saido, T. C. (2012) Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology. FASEB J. 26, 1204-1217
40. Le Corre, S., Klafki, H. W., Plesnila, N., Hübinger G., Obermeier, A., Sahagu ́n, H., Monse, B., Seneci, P., Lewis, J., Eriksen, J., Zehr, C., Yue, M., McGowan, E., Dickson, D. W., Hutton, M., and Roder, H. M. (2006) An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc. Nat. Acad. Sci. 103, 9673-9678
41. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human kinome. Science 298, 1912-1934